For dogs with atopic dermatitis, CYTOPOINT® offers a full month of relief with a single in-clinic injection1, helping to improve the quality of life for dogs and their families
TARGETED
Targets and neutralises interleukin (IL)-31, a key itch-inducing cytokine in atopic dermatitis2
WORKS FAST AND LASTS
Begins working within 8 hours and delivers a full month of relief* from the clinical signs of atopic dermatitis1; in-clinic administration ensures compliance
FLEXIBLE
Can be used in dogs of all ages, even those with concomitant disease as well as alongside many common medications1
Indication: CYTOPOINT treats clinical manifestations of atopic dermatitis in dogs.
Repeat administration monthly as needed in the individual patient.
References: 1. CYTOPOINT Summary of Product Characteristics 2. Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53. doi:10.1111/j.1365-3164.2012.01098.x.
The material contained within this website is intended to be viewed by practising veterinary surgeons in the UK only. The drugs listed in this website may have different technical specifications approved in other countries.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2017 Zoetis Services LLC. All rights reserved. MM-01580
